Physicochemical Stability Study of Oral Suspension Containing Ruxolitinib in Children with Steroid-Refractory Acute Graft-Versus-Host Disease

<div>Chromatograms of ruxolitinib in Inorpha® at 200 <i>μ</i>g/mL (a), blank with just Inorpha (b), and ruxolitinib alone obtained from an analytical standard at 200 <i>μ</i>g/mL (c).</div>

The Scientific World Journal

fig1

Figure 1

Figure 1: Physicochemical Stability Study of Oral Suspension Containing Ruxolitinib in Children with Steroid-Refractory Acute Graft-Versus-Host Disease 

Figure 1 | Physicochemical Stability Study of Oral Suspension Containing Ruxolitinib in Children with Steroid-Refractory Acute Graft-Versus-Host Disease 